December 07, 2012
Pfizer Inc., Genentech Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals LLC on Friday sued Roxane Laboratories Inc. in Delaware federal court over the generic-drug maker's bid for approval to market a version of the cancer treatment Tarceva for the second time this year.